(Q40468453)

20 September 2017

1 reference

title

Treatment of AIDS with Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle (English)

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

16 July 2024

author name string

P. S. Sarin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7650288

16 July 2024

A. L. Goldstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7650288

16 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7650288

16 July 2024

publication date

1 May 1995

1 reference

full work available at URL

20 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/08923979509019748

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Immunopharmacology and Immunotoxicology

16 July 2024

published in

1 reference

20 September 2017

volume

17

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

217-245

1 reference

Molecular pharmacologic approaches to the treatment of AIDS.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

The immunopathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of HTLV-III/LAV replication by foscarnet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

HIV inhibitors targeted at the reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: anti-HIV activity, physical properties, and interaction with plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Strategies for antiviral therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Human immunodeficiency virus. Playing chess with reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

A Phospholipid Derivative of Cytosine Arabinoside and Its Conversion to Phosphatidylinositol by Animal Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-beta-D-arabinofuranosylcytosine 5-diphosphate-L-1,2-diacylglycerols.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of HIV replication by naphthalenemonosulfonic acid derivatives and a bis naphthalenedisulfonic acid compound

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of HIV replication by derivatives of naphthalenedisulfonic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Significant Anti-HIV Activity of New Modified Poly Anionic Polymersin vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Structure-based, C2 symmetric inhibitors of HIV protease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Effect of a human immunodeficiency virus protease inhibitor on human monocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Inhibition of HIV replication by Hyssop officinalis extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

A soluble factor induced by an extract from Pinus parviflora Sieb et Zucc can inhibit the replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Potent inhibitory effect of a series of modified cyclodextrin sulfates (mCDS) on the replication of HIV-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Dextran sulfate is poorly absorbed after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509019748

Targeted therapy of human immunodeficiency virus‐related disease

21 January 2018

4

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

16 July 2024

9

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase

16 July 2024

10

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone

16 July 2024

27

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group

16 July 2024

30

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro

16 July 2024

31

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet

16 July 2024

32

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine

16 July 2024

33

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1

16 July 2024

36

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro

16 July 2024

49

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Protooncogenes in the regulation of normal hematopoiesis. An antisense approach

16 July 2024

51

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

16 July 2024

56

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

Effects of GLQ223 on HIV replication in human monocyte/macrophages chronically infected in vitro with HIV.

16 July 2024

67

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study.

16 July 2024

68

1 reference

https://api.crossref.org/works/10.3109/08923979509019748

16 July 2024

Identifiers

1 reference

20 September 2017

1 reference